Verici Dx plc reported earnings results for the half year ended June 30, 2024. For the half year, the company reported sales was USD 3.34 million compared to USD 0.019 million a year ago. Net loss was USD 1.35 million compared to USD 5.27 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.75 GBX | -1.46% |
|
+3.85% | -30.77% |
Jul. 16 | Transcript : Verici Dx plc, Q2 2024 Earnings Call, Jul 16, 2024 | |
Jul. 15 | EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises | AN |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.77% | 21.52M | |
-6.61% | 12.07B | |
+96.15% | 8.2B | |
-18.38% | 6.59B | |
+9.13% | 5.89B | |
-21.66% | 3.47B | |
+5.36% | 2.52B | |
+41.54% | 2.48B | |
+17.72% | 2.3B | |
-18.43% | 1.58B |
- Stock Market
- Equities
- VRCI Stock
- News Verici Dx plc
- Verici Dx plc Reports Earnings Results for the Half Year Ended June 30, 2024